Literature DB >> 3146586

Immunomodulation by indoleamines: serotonin and melatonin action on DNA and interferon-gamma synthesis by human peripheral blood mononuclear cells.

E S Arzt1, S Fernández-Castelo, L M Finocchiaro, M E Criscuolo, A Díaz, S Finkielman, V E Nahmod.   

Abstract

Different concentrations of indoleamines, serotonin and melatonin, inhibited phytohemagglutinin stimulated DNA synthesis. Thus, 10(-3) to 10(-4) M of either indoleamine acted at the optimal phytohemagglutinin concentration, while 10(-3) to 10(-7) M acted at suboptimal phytohemagglutinin levels. The serotonin effect was reversed by the serotonergic S1-S2 receptor antagonist methysergide but not by the S2 antagonist ketanserin. This indicates that only the S1 receptor is involved in the inhibitory effect. Inhibition of lymphoproliferation by indoleamines was also exerted on pokeweed mitogen and protein A from Staphylococcus aureus stimulations. Serotonin and melatonin also inhibited phytohemagglutinin and protein A from Staphylococcus aureus induction of interferon-gamma synthesis. The initial uptake of Ca2+ was not affected by indoleamines, suggesting that it is not the mechanism of their inhibitory effects. As interferon-gamma induced tryptophan uptake by T lymphocyte- and macrophage-depleted populations, and tryptophan is the metabolic precursor of serotonin and melatonin, a new immunoregulatory circuit is postulated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146586     DOI: 10.1007/bf00916958

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  16 in total

1.  Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity.

Authors:  G I Byrne; L K Lehmann; J G Kirschbaum; E C Borden; C M Lee; R R Brown
Journal:  J Interferon Res       Date:  1986-08

2.  Recombinant interleukin 2 rapidly augments human natural killer cell activity.

Authors:  D Kabelitz; H Kirchner; D Armerding; H Wagner
Journal:  Cell Immunol       Date:  1985-06       Impact factor: 4.868

3.  Neuroimmunology: modulation of the hamster immune system by photoperiod.

Authors:  G C Brainard; R L Knobler; P L Podolin; M Lavasa; F D Lublin
Journal:  Life Sci       Date:  1987-03-30       Impact factor: 5.037

4.  Neuroanatomic and neurotransmitter influences on immune function.

Authors:  T L Roszman; J C Jackson; R J Cross; M J Titus; W R Markesbery; W H Brooks
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Angiotensin II regulates interferon-gamma production.

Authors:  S Fernandez-Castelo; E S Arzt; A Pesce; M E Criscuolo; A Diaz; S Finkielman; V E Nahmod
Journal:  J Interferon Res       Date:  1987-06

6.  Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones.

Authors:  W C Koff; M A Dunegan
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines.

Authors:  D S Finbloom; D L Hoover; L M Wahl
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  Influence of serotonin on the immune response.

Authors:  J C Jackson; R J Cross; R F Walker; W R Markesbery; W H Brooks; T L Roszman
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

10.  Recombinant mouse interferon-gamma regulation of antibody production.

Authors:  H M Johnson; B A Torres
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more
  14 in total

1.  Opposite effects of serotonin and interferon-alpha on the membrane potential and function of human natural killer cells.

Authors:  Tibor Oláh; Imre Ocsovszki; Yvette Mándi; Rozália Pusztai; Márta Bakay; Elisabeth Balint
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Tryptophan and eosinophilia-myalgia syndrome.

Authors:  P A Hertzman; R R Brown
Journal:  West J Med       Date:  1991-02

3.  TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH.

Authors:  S Raiden; E Polack; V Nahmod; M Labeur; F Holsboer; E Arzt
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

4.  Immunocytochemical and electron-microscopic characterization of macrophage/microglia cells and expression of class II major histocompatibility complex in the pineal gland of the rat.

Authors:  E B Pedersen; L M Fox; A J Castro; J A McNulty
Journal:  Cell Tissue Res       Date:  1993-05       Impact factor: 5.249

5.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1990-09

6.  Characterization of Interleukin-2 (IL-2) receptor expression and action of IL-2 and IL-6 on normal anterior pituitary cell growth.

Authors:  E Arzt; J Sauer; R Buric; J Stalla; U Renner; G K Stalla
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

7.  Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures.

Authors:  E Arzt; G Stelzer; U Renner; M Lange; O A Müller; G K Stalla
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes.

Authors:  L M Finocchiaro; V E Nahmod; J M Launay
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

Review 9.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Low lymphocyte interferon-gamma production and variable proliferative response in anorexia nervosa patients.

Authors:  E Polack; V E Nahmod; E Emeric-Sauval; M Bello; M Costas; S Finkielman; E Arzt
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.